Editas Medicine, Inc. - EDIT

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Jun 03, 2026 SCHEDULE 13G RA Capital Management, L.P. 5.8% 8,889,000 View
Jun 03, 2026 SCHEDULE 13G Peter Kolchinsky 5.8% 8,889,000 View
Jun 03, 2026 SCHEDULE 13G Rajeev Shah 5.8% 8,889,000 View
Jun 03, 2026 SCHEDULE 13G RA Capital Healthcare Fund, L.P. 5.8% 8,889,000 View
Jun 03, 2026 SCHEDULE 13G TCG Crossover GP III, LLC 9.9% 15,798,999 View
Jun 03, 2026 SCHEDULE 13G TCG Crossover Fund III, L.P. 9.9% 15,798,999 View
Jun 03, 2026 SCHEDULE 13G Chen Yu 9.9% 15,798,999 View
Jun 02, 2026 SCHEDULE 13G Commodore Capital LP 9.9% 16,045,802 View
Jun 02, 2026 SCHEDULE 13G Commodore Capital Master LP 9.9% 16,045,802 View
Jun 02, 2026 SCHEDULE 13G Robert Egen Atkinson 9.9% 16,045,802 View
Jun 02, 2026 SCHEDULE 13G Michael Kramarz 9.9% 16,045,802 View
Mar 26, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.